TCF7L2 and breast carcinoma: The cancer gene TCF7L2 [45] is a component of the Wnt pathway, a recurrent fusion oncogene in human CRC [46, 47], mutated in 14% of CRCs and breast cancers and a transposon target in murine genetic models of CRCs, liver tumors, and brain tumors [39].